These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3410609)

  • 21. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The involvement of histamine receptors in morphine-induced increased naloxone potency in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):69-74. PubMed ID: 3990446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of histamine in human placental perfusate and the effect of histamine releasers.
    Kohler FW; Gautieri RF; Mann DE
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):185-200. PubMed ID: 2460906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intravenous or subarachnoid morphine on cerebral and spinal cord hemodynamics and antagonism with naloxone in dogs.
    Matsumiya N; Dohi S
    Anesthesiology; 1983 Sep; 59(3):175-81. PubMed ID: 6881580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term effect of morphine on the thyroid gland in male rats.
    Tal E; Korányi L; Kovács Z; Endröczi E
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):511-4. PubMed ID: 6326448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of intracerebral naloxone on plasma corticosterone and growth hormone levels in morphine dependent rats.
    Mentzer G; George R; Garcia JF
    Proc West Pharmacol Soc; 1977; 20():385-8. PubMed ID: 408822
    [No Abstract]   [Full Text] [Related]  

  • 28. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma histamine and catecholamine levels during hypotension induced by morphine and compound 48/80.
    Muldoon SM; Freas W; Mahla ME; Donlon MA
    J Cardiovasc Pharmacol; 1987 May; 9(5):578-83. PubMed ID: 2439840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine release as the basis for morphine action on bile duct and sphincter of Oddi.
    Ehrenpreis S; Kimura I; Kobayashi T; Kimura M
    Life Sci; 1987 Apr; 40(17):1695-8. PubMed ID: 2436022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone improves, and morphine exacerbates, experimental shock induced by release of endogenous histamine by compound 48/80.
    Amir S
    Brain Res; 1984 Apr; 297(1):187-90. PubMed ID: 6722534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compound 48/80, a histamine-depleting agent, blocks the protective effect of morphine against electroconvulsive shock in mice.
    Karadag CH; Dokmeci D; Dost T; Ulugol A; Dokmeci I
    Braz J Med Biol Res; 2000 Mar; 33(3):327-30. PubMed ID: 10719385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothermia enhances the effects of morphine on hormonal and histamine release.
    Alcaraz C; Bansinath M; Turndorf H; Puig MM
    Clin Exp Pharmacol Physiol; 1989 May; 16(5):367-74. PubMed ID: 2475284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of mast cell disruption in the acute manifestations of the intravenous injection of morphine in dogs.
    Akcasu A; Unna KR
    Eur J Pharmacol; 1970; 13(1):103-7. PubMed ID: 4099990
    [No Abstract]   [Full Text] [Related]  

  • 35. Blood histamine levels and arteriovenous concentration differences after the intravenous administration of the basic compounds l-3 and 48/80 in the anaesthetized dog.
    Schütz W; Kolassa N; Kraupp O
    Pharmacology; 1975; 13(2):143-54. PubMed ID: 49901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of mast cells in the genesis of acute manifestations following the intravenous injection of meperidine in dogs.
    Akcasu A; Yillar DO; Akkan AG; Küçkhüseyin C
    J Basic Clin Physiol Pharmacol; 2009; 20(1):67-72. PubMed ID: 19601396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in plasma cyclic AMP levels elicited by naloxone in morphine-dependent male mice.
    Muraki T; Tokunaga Y; Makadate T; Kato R
    Neuropharmacology; 1981 Feb; 20(2):177-81. PubMed ID: 6259549
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-mercaptoethylamine and cystamine-induced histamine release in the dog.
    Mundy RL; Demaree GE; Jacobus DP; Heiffer MH
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):64-70. PubMed ID: 4166151
    [No Abstract]   [Full Text] [Related]  

  • 39. [Radioimmunological demonstration of morphine in hematoma blood in a day-and-half survived accident].
    Gelbke HP; Bösche J
    Arch Kriminol; 1977; 159(1-2):31-5. PubMed ID: 843161
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of naloxone on morphine-induced changes in ACTH, corticosterone and cyclic nucleotides.
    Ho WK; Lam S; Leung KC; Au KK; Wong HK; Tsang YF; Wen HL
    Neuropharmacology; 1978 Jun; 17(6):397-400. PubMed ID: 209366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.